Masimo has obtained CE-Mark and launched its new RD rainbow Lite SET sensors developed to monitor Masimo Oxygen Reserve Index (ORi) and RPVi along with its SET Measure-through Motion and Low Perfusion pulse oximetry.
RPVi is an improved version of PVi designed to enable inexpensive, non-invasive and continuous assessment of fluid responsiveness.
The ORi parameter provides information on oxygen reserve in the moderate hyperoxic range and, when combined with SET pulse oximetry, it is expected to deliver an advanced warning of desaturation.
ORi is reported to have been validated in two separate studies with paediatric and adult patients.
The new lightweight sensors are intended to boost patient comfort and optimise clinician workflow. They possess an intuitive sensor-to-cable feature to enable a proper connection.
Masimo founder and CEO Joe Kiani said: “rainbow Lite sensors allow clinicians, who depend on powerful SET pulse oximetry technology, to augment their patient monitoring with ORi and newly introduced RPVi.
“Given the positive reception of ORi in available markets, and feedback from clinicians who see great value in the benefits of ORi monitoring, we are excited to make ORi and RPVi accessible via the cost-effective solution represented by RD rainbow Lite SET.”
In addition to the RD rainbow Lite SET that uses four wavelengths, Masimo RD sensors range includes the RD SET with two wavelengths and SET pulse oximetry.
The line further contains RD rainbow SET having more than seven wavelengths to measure non-invasive parameters, including SpHb (total hemoglobin), SpCO (carboxyhemoglobin), SpMet (methemoglobin), and SpOC (oxygen content).